Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin R Goding
Heinz Arnheiter

Genes & development

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Genes & Development|May 25, 2019
MITF-the first 25 yearsColin R Goding, Heinz Arnheiter
Genes & Development|October 3, 2019
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunitiesFlorian Rambow, Jean-Christophe Marine, Colin R Goding
Genes & Development|December 22, 2006
Mitf regulation of Dia1 controls melanoma proliferation and invasivenessSuzanne Carreira, Jane Goodall, Laurence Denat, et al.
Genes & Development|November 25, 2021
TBX2 controls a proproliferative gene expression program in melanomaSizhu Lu, Pakavarin Louphrasitthiphol, Nishit Goradia, et al.
Genes & Development|November 17, 2007
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma developmentVéronique Delmas, Friedrich Beermann, Silvia Martinozzi, et al.
Genes & Development|February 5, 2024
DNA damage remodels the MITF interactome to increase melanoma genomic instabilityRomuald Binet, Jean-Philippe Lambert, Marketa Tomkova, et al.
Genes & Development|February 27, 2025
Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progressionAna Chocarro-Calvo, Miguel Jociles-Ortega, José Manuel García-Martinez, et al.
Genes & Development|February 27, 2019
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanomaKatharine Herbert, Romuald Binet, Jean-Philippe Lambert, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Genes & Development|May 25, 2019
MITF-the first 25 yearsColin R Goding, Heinz Arnheiter
Genes & Development|October 3, 2019
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunitiesFlorian Rambow, Jean-Christophe Marine, Colin R Goding
Genes & Development|December 22, 2006
Mitf regulation of Dia1 controls melanoma proliferation and invasivenessSuzanne Carreira, Jane Goodall, Laurence Denat, et al.
Genes & Development|November 25, 2021
TBX2 controls a proproliferative gene expression program in melanomaSizhu Lu, Pakavarin Louphrasitthiphol, Nishit Goradia, et al.
Genes & Development|November 17, 2007
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma developmentVéronique Delmas, Friedrich Beermann, Silvia Martinozzi, et al.
Genes & Development|February 5, 2024
DNA damage remodels the MITF interactome to increase melanoma genomic instabilityRomuald Binet, Jean-Philippe Lambert, Marketa Tomkova, et al.
Genes & Development|February 27, 2025
Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progressionAna Chocarro-Calvo, Miguel Jociles-Ortega, José Manuel García-Martinez, et al.
Genes & Development|February 27, 2019
BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanomaKatharine Herbert, Romuald Binet, Jean-Philippe Lambert, et al.
Genes & Development|January 19, 2017
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanomaPaola Falletta, Luis Sanchez-Del-Campo, Jagat Chauhan, et al.
Pageof 1